Literature DB >> 17902020

Intra-abdominal use of taurolidine or heparin as alternative products to an antiadhesive barrier (Seprafilm) in adhesion prevention: an experimental study on mice.

Isamettin Bahadir1, Mustafa Oncel, Metin Kement, Yusuf Sahip.   

Abstract

PURPOSE: Seprafilm (Genzyme Biosurgery, Cambridge, MA) remains a widely used product in postoperative adhesion prevention. This study was designed to compare the antiadhesive effects of taurolidine, heparin, and Seprafilm in a murine cecal abrasion model.
METHODS: Sixty male Balb/c mice underwent a cecal abrasion procedure and were randomized into four groups (n = 15 in each). Groups T, H, and S animals intraperitoneally received taurolidine, heparin, and Seprafilm, respectively, and Group C animals were reserved as control. Animals were killed on Day 21, and the severity of adhesions was evaluated with a scoring system ranging between 0 to 5. In addition, the localizations of the adhesions were questioned.
RESULTS: Five (1 in Group S and 4 in Group H) animals died before they were killed. The deaths were related to intra-abdominal bleeding, and mortality rate was significantly higher in Group H than those in other groups (P < 0.05 for each comparison). The severity of adhesions was significantly less in the study groups than Group C, and in Group H than Groups T and S (P < 0.05 for each comparison). In addition, adhesions located cecum over itself were significantly less in the study groups than the control group, and those between small bowel and cecum were significantly lower in Groups T and S than the control group (P < 0.05 for each comparison).
CONCLUSIONS: All products are effective in adhesion prevention. Heparin use provides the best results but may be associated with a higher mortality rate related to intra-abdominal bleeding. Taurolidine may be an alternative product to Seprafilm , but further studies are required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17902020     DOI: 10.1007/s10350-007-9074-6

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Peritoneal infusion with cold saline decreased postoperative intra-abdominal adhesion formation.

Authors:  Cheng-Chung Fang; Tzung-Hsin Chou; Geng-Shiau Lin; Zui-Shen Yen; Chien-Chang Lee; Shyr-Chyr Chen
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

2.  Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.

Authors:  Birgit Hotz; Ulrike Erben; Marco Arndt; Heinz J Buhr; Hubert G Hotz
Journal:  Int J Colorectal Dis       Date:  2014-09-03       Impact factor: 2.571

3.  Development of novel biocompatible thermosensitive anti-adhesive agents using human-derived acellular dermal matrix.

Authors:  Jong Ju Jeong; Dong Won Lee; Seung Yong Song; Yerin Park; Ji Hee Kim; Jang Il Kim; Hyung Goo Kim; Ki Taek Nam; Won Jai Lee; Kee-Hyun Nam; Ju Hee Lee
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

4.  Efficacy and safety of temperature-sensitive acellular dermal matrix in prevention of postoperative adhesion after thyroidectomy: A randomized, multicenter, double-blind, non-inferiority study.

Authors:  Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Sung-Rae Cho; Seongmoon Jo; Eun Young Kim; Ji-Sup Yun; Hee Jin Park; Mi Sung Kim; Kwangsoon Kim; Sohee Lee; Ja Seong Bae; So Yeon Jun; Jihye Park; Jeong Soo Kim
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

5.  Seprafilm® adhesion barrier: (1) a review of preclinical, animal, and human investigational studies.

Authors:  Michael P Diamond; Ellen L Burns; Beverly Accomando; Sadiqa Mian; Lena Holmdahl
Journal:  Gynecol Surg       Date:  2012-04-20

Review 6.  Peritoneal response to abdominal surgery: the role of equine abdominal adhesions and current prophylactic strategies.

Authors:  Juliana de Moura Alonso; Ana Liz Garcia Alves; Marcos Jun Watanabe; Celso Antonio Rodrigues; Carlos Alberto Hussni
Journal:  Vet Med Int       Date:  2014-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.